FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law RFK Jr. & claimed regenerative peptides like BPC 157 The Niche